SavedAdd your journal

Journals / Türk Onkoloji Dergisi / 2019 / Cilt: 34 - Sayı: 4

Factors that are Effective in Surgery Preferences of Patients Diagnosed with Breast Cancer who are Admitted to Radiation Oncology Clinics

Sema YILMAZ RAKICI
Pages
248–255
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Significantly moreBCSs were found to be performed when the tumor diameter was less than 2.5 cm, and more MRMswere performed as the nodal stage increased (p=0.000, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVEIn this study, the factors affecting the choice of treatment were investigated in patients diagnosed withbreast cancer who were treated with breast-conserving surgery or mastectomy.METHODSFactors that may be effective in surgical choice were aimed to be determined by retrospectively examining patient files regarding age, pathological type, diameter and lateralization of the tumor, number oflymph nodes in the axilla, estrogen and progesterone receptor (ER and PR), c-erbB-2 status, the place ofresidence, center of operation and distribution of patients according to years.
📊
Key Findings & Data:The relationships amongthe data in this study were examined using statistical methods.RESULTSThe mean age of the patients was 52.06±11.91 (age range: 28–86).
💡
Conclusion & Impact:Significantly moreBCSs were found to be performed when the tumor diameter was less than 2.5 cm, and more MRMswere performed as the nodal stage increased (p=0.000, p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVEIn this study, the factors affecting the choice of treatment were investigated in patients diagnosed withbreast cancer who were treated with breast-conserving surgery or mastectomy.METHODSFactors that may be effective in surgical choice were aimed to be determined by retrospectively examining patient files regarding age, pathological type, diameter and lateralization of the tumor, number oflymph nodes in the axilla, estrogen and progesterone receptor (ER and PR), c-erbB-2 status, the place ofresidence, center of operation and distribution of patients according to years. The relationships amongthe data in this study were examined using statistical methods.RESULTSThe mean age of the patients was 52.06±11.91 (age range: 28–86). Tumor lateralization was the right sidein 44.4% of the patients and the left side in 55.6% of the patients. There were significantly more modified radical mastectomy (MRM) surgeries in the cases with left-sided lateralization and more breastconserving surgeries (BCS) in the patients with right-sided lateralization (p=0.001). Significantly moreBCSs were found to be performed when the tumor diameter was less than 2.5 cm, and more MRMswere performed as the nodal stage increased (p=0.000, p

🔖

Cite This Article

RAKICI, S. Y. (2022). Factors that are Effective in Surgery Preferences of Patients Diagnosed with Breast Cancer who are Admitted to Radiation Oncology Clinics. Türk Onkoloji Dergisi, Cilt: 34 - Sayı: 4, 248–255. https://ajindex.com/articles/639206

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Halsted WS. I. A Clinical and Histological Study of certain Adenocarcinomata of the Breast: and a Brief Consideration of the Supraclavicular Operation and of the Results of Operations for Cancer of the Breast from 1889 to 1898 at the Johns Hopkins Hospital. Ann Surg. 1898;28(5):557-–76
  2. Fisher B, Fisher ER. Transmigration of lymph nodes by tumor cells. Science 1966;152(3727):1397–8
  3. Fisher B, Fisher ER. The interrelationship of hematogenous and lymphatic tumor cell dissemination. Surg Gynecol Obstet 1966;122(4):791–8
  4. Fisher B, Anderson SJ. The breast cancer alternative hypothesis: is there evidence to justify replacing it? J Clin Oncol 2010;28(3):366–74
  5. Cardoso F, Senkus E, Costa A, Papadopoulos E, Aapro M, André F, et al. 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†. Ann Oncol 2018;29(8):1634–57
  6. Franceschini G, Martin Sanchez A, Di Leone A, Magno S, Moschella F, Accetta C, et al. New trends in breast cancer surgery: a therapeutic approach increasingly efficacy and respectful of the patient. G Chir 2015;36(4):145–52
  7. Keynes G. Conservative Treatment of Cancer of the Breast. Br Med J 1937;2(4004):643–66.3
  8. Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, et al. Radiotherapy after breastpreserving surgery in women with localized cancer of the breast. N Engl J Med 1993;328(22):1587–91
  9. Litière S, Werutsky G, Fentiman IS, Rutgers E, Christiaens MR, Van Limbergen E, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol 2012;13(4):412–9. 10.Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Eng J Med 1995;333(22):1456–61. 11.Lazovich D, White E, Thomas DB, Moe RE. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 1991;266(24):3433–8. 12.Young WW, Marks SM, Kohler SA, Hsu AY. Dissemination of clinical results: mastectomy versus lumpectomy and radiation therapy. Med Care 1996;34(10):1003–17. 13.Farrow DC, Hunt WC, Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992;326(17):1097–101. 14.Athas WF, Adams-Cameron M, Hunt WC, Amir-Fazli A, Key CR. Travel distance to